Zetagen Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company pioneering first-of-its-kind, intratumoral treatments for metastatic and primary breast cancer, announced the successful closure of its
Algorithm, a pioneering regional pharmaceutical manufacturer has announced the signing of a strategic partnership agreement with Batterjee Pharma, a leading Saudi pharmaceutical company, becoming the
License enables SS&C to deliver integrated wealth management technology and services across the European Union from its Dublin hub SS&C Technologies Holdings, Inc. announced significant expansion
Vyome Holdings, Inc. a clinical-stage healthcare holding company, announced Dr. Aditya Bardia as Senior Medical Advisor to Vyome. In this consulting role, Dr. Bardia will
Eli Lilly and Company, listed on the NYSE as LLY, announced that new data from its breast oncology pipeline and approved medicines will be highlighted
Impilo, a leading provider of at-home healthcare solutions through software, logistics, and operational support, has announced a strategic partnership with Eko Health, a company specializing
Eisai Co., Ltd., headquartered in Tokyo with CEO Haruo Naito, and Biogen Inc., based in Cambridge, Massachusetts, with CEO Christopher A. Viehbacher, announced that Eisai
VSI Spine Surgeon Dr. Christopher Good has reached a groundbreaking milestone in robotic spine surgery by performing the world’s first minimally invasive robotic Bertolotti’s resection
Illume Fertility, a leading fertility practice in the tri-state area known for its award-winning physicians, patient-focused care, and advanced reproductive treatments, has introduced a new
Ovation.io, a leading human omics and clinical data company, and PrecisionLife, a precision medicine firm transforming the understanding and management of complex chronic diseases, have
US Fertility, the nation’s leading fertility services platform, announced a new strategic partnership with L Catterton, the largest global consumer-focused private equity firm, and Amulet Capital Partners,
Virginia Cancer Specialists, recognized as the top cancer practice in Virginia, has announced the addition of Christopher R. Johnson, MD, to its team of thoracic
